Abstract
The aim of this study was to investigate the relationship between prostate specific antigen density and prostate volume with microvessel density in patients with benign prostatic hyperplasia and advanced prostatic carcinoma. Sixty-eight patients with benign prostatic hyperplasia and 11 patients with advanced prostatic carcinoma participated in the study. The paraffin blocks of all patients were stained with CD34 by the standard immunohistochemical technique and microvessel density, prostate specific antigen density and prostatic volume were determined. In patients with benign prostatic hyperplasia the mean microvessel density, mean prostate specific antigen density and mean prostatic volume were 74±89±22.73, 0.12±0.10 and 59.97±27.0 ml, respectively. There was no correlation between prostate specific antigen density and mean prostatic volume or microvessel density (r=0.079 and −0.095, respectively).
In patients with advanced prostatic carcinoma the mean microvessel density, mean prostate specific antigen density and mean prostatic volume were 147.90±47.55, 0.63±0.41 and 54.00±22.42 ml, respectively. In this group, while there was a good correlation between prostate specific antigen density and microvessel density (r=0.785), no significant correlation was found between prostatic volume and microvessel density (r=−0.07). There was significant statistical difference in patients with advanced prostatic carcinoma compared to patients with benign prostatic hyperplasia in terms of mean microvessel density (p<0.0001). The findings that there was no correlation between prostatic volume and MVD either in benign prostatic hyperplasia or in prostatic carcinoma suggest that microvessel development is not correlated with prostatic volume but may be correlated with morphology.
Similar content being viewed by others
References
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.N. Engl. J. Med., 317, 909 (1987).
Bahnson, R. R.: Elevationof prostate-specific antigen from bacillus Calmette-Guerin induced granulomatous prostatitis.J. Urol., 146, 1368 (1991).
Neal, D. E. Jr., Clejan, S., Sarma, D., Moon, T. D.: Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and non-human primate.Prostate, 20, 105 (1992).
Yuan, J. J., Coplen, D. E., Petros, J. A., Figenshau, R. S., Ratliff, T. L., Smith, D. S., Catalona, W. J.: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.J. Urol., 147, 810 (1992).
Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J., Connor, W. H.: The use of prostate-specific antigen density to enhance the predictive value of intermediate levels of serum prostate-specific antigen.J. Urol., 147, 817 (1992).
Brawer, M. K., Deering, R. E., Brown, M., Preston, S. D., Bigler, S. A.: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity.Cancer, 73, 678 (1994).
Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S., Ushigome, S.: Tumor angiogenesis in prostatic carcinoma with and without boen marrow metastasis: A morphometric study.J. Pathol., 168, 257 (1992).
Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., Folkman, J.: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.Am. J. Pathol., 143, 401 (1993).
Hall, M. C., Troncoso, P., Pollack, A., Zhau, H. y., Zagars, G. K., Chung, L. W., von Eschenbach, A. C.: Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.Urology, 44, 869 (1994).
Bigler, S. A., Deering, R. E., Brawer, M. K.: Comparison of microscopic vascularity in benign and malignant prostate tissue.Hum. Pathol., 24 (2), 220 (1993).
Christensson, A., Laurell, C. B., Lilja, H.: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors.Eur. J. Biochem., 194, 755 (1990).
Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K., Lövgren, T.: Prostate-specific antigen in human serum occurs predominantly in complex with α1-antichymotrypsin.Clin. Chem., 37, 1618 (1991).
Bigler, S. A., Deering, R. E., Brawer, M. K.: A quantitative morphometric analysis of the microcirculation in the prostate carcinoma.Hum. Pathol., 24, 220 (1993).
Deering, R. E., Bigler, S. A., Brown, M., Brawer, M. K.: Microvascularity in benign prostatic hyperplasia.Prostate, 26, 111 (1995).
Leibovich, S. J., Polverinin, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., Nusier, N.: Macrophage induced angiogenesis is mediated by tumour necrosis factor-a.Nature, 329, 630 (1987).
Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van der Water, L., Dvorak, A. M., Dvorak, H. F.: Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition.Biochem. Biophys. Acta, 948, 305 (1988).
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., Feder, J.: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.J. Clin. Invest., 84, 1470 (1989).
Folkman, J., Shing, Y.: Angiogenesis.J. Biol. Chem., 267, 1093 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Çetinkaya, M., Günçe, S., Ulusoy, E. et al. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma. International Urology and Nephrology 30, 581–585 (1998). https://doi.org/10.1007/BF02550549
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550549